Neurofeedback and Attention-Deficit/Hyperactivity-Disorder (ADHD) in Children: Rating the Evidence and Proposed...

Area of Science:

• Neuroscience
• Clinical Psychology
• Behavioral Science

Background:

• Attention-Deficit/Hyperactivity-Disorder (ADHD) is commonly treated with stimulant medication and behavioral therapy.
• Neurofeedback (NFB) is a non-pharmacological intervention whose efficacy as a standalone ADHD treatment requires further empirical validation.

Purpose of the Study:

• To evaluate the efficacy and effectiveness of standard neurofeedback protocols for ADHD.
• To determine if neurofeedback meets criteria for a 'well-established' treatment according to updated APA guidelines.
• To compare neurofeedback's long-term effects with those of medication and behavioral therapy.

Main Methods:

• Quantitative review utilizing updated APA guidelines for 'well-established' treatments.
• Inclusion of recent systematic reviews, meta-analyses, and multi-center randomized controlled trials (RCTs).
• Focus on efficacy, effectiveness, effect sizes (ES), remission rates, and long-term outcomes.

Main Results:

• Two meta-analyses confirmed significant efficacy of NFB for ADHD symptoms (medium ES), with sustained effects at 6-12 months.
• Four multi-center RCTs showed NFB superiority over control groups (medium-large ES), with 32-47% remission rates.
• Open-label studies confirmed effectiveness, with no publication bias or significant NFB-specific side effects.

Conclusions:

• Standard neurofeedback protocols are a well-established ADHD treatment.
• NFB demonstrates medium to large effect sizes, 32-47% remission rates, and sustained effects.
• Neurofeedback offers a viable non-pharmacological option for ADHD management.